Home › Compound Library › Immune & Anti-Aging › Thymosin Alpha-1 Extended Protocol
Immune & Anti-Aging Research Moderate Evidence

Thymosin Alpha-1 Extended Protocol

Thymosin alpha-1 (Zadaxin) in extended/chronic administration research protocols — distinct from standard acute infection courses. Studied for long-term immunosenescence reversal, chronic viral infection suppression, and longevity applications in aging immune systems.

thymosinextended protocolimmunosenescencelongevitychronic viralagingimmune remodeling
Half-life
~2 hours; extended protocol compensates via frequent dosing (3x/week or daily)
SKUs Available
1
Evidence Level
Moderate Evidence
Mechanism of Action

Same mechanism as standard TA-1 (TLR-9 agonist, DC activation, NK enhancement, Th1 polarization) but studied over 6–12 month continuous or pulsatile protocols to assess sustained immune remodeling vs acute stimulation effects. Cumulative epigenetic immune reprogramming hypothesized.

Published Research Ranges & Study Context

Studies have administered: 1.6–3.2mg SC, 3x/week or daily for 6–12 month extended protocols in aging/chronic disease research

Important Research Framing These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings

Italian centenarian study: elderly with high thymosin alpha-1 had better immune profiles. Chronic HBV 52-week protocol: superior viral suppression vs standard courses. COVID-19 severe disease: survival benefit in retrospective Chinese cohort. Extended protocol data growing.

Moderate Evidence Phase 1/2 human trials available
Side Effects Observed in Research

Excellent tolerability maintained across long-course studies; injection site fatigue main complaint; no significant cumulative toxicity documented

Available Configurations (SKU Reference)
TA1-EXT
Compounds Studied in Combination

These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.

Want a Complete Research Monograph?

Our AI can generate a 2,000+ word deep-dive on Thymosin Alpha-1 Extended Protocol — including full clinical trial summaries, pharmacokinetics, and research frontiers.

Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.